Recent Updates
Recently added Catalysts
INKT Positive Sentiment Score: 60/100

MiNK Therapeutics to Report First Quarter 2023 Corporate Update and Financial Results

Thursday, April 27, 2023 1 min read
Key Takeaway: MiNK Therapeutics, a clinical-stage biopharmaceutical company, will report its first quarter 2023 financial results on May 11, 2023, before market opening. The leadership team will host a conference call at 8:30 a.m. ET to discuss these results and provide an update on corporate matters. Investors can access the call via dial-in numbers and also through a live webcast on the company's website.

Market Sentiment Analysis

POSITIVE FACTORS

  • Company set to report key financial results and corporate updates.
  • MiNK Therapeutics is focused on innovative therapies targeting cancer.
  • The webcast allows for wider investor engagement.

Full Press Release Details

NEW YORK, April 27, 2023 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases, today announced that the Company will release its first quarter 2023 financial results before the market opens on Thursday, May 11, 2023. Members of the MiNK leadership team will host a conference call and webcast at 8:30 a.m. ET that morning to discuss the results and to provide a corporate update.
Dial in numbers: 646-307-1963 (USA-NY), 800-715-9871 (USA & Canada)
Conference ID: 8437743
A live webcast and replay of the conference call will be accessible from the Events & Presentations page of the Company’s website at https://investor.minktherapeutics.com/events-and-presentations and via https://edge.media-server.com/mmc/p/4c4qmbci.
About MiNK Therapeutics
communications@minktherapeutics.com
investor@minktherapeutics.com

Frequently Asked Questions

When does MiNK Therapeutics plan to release Q1 2023 results?

MiNK Therapeutics will release its Q1 2023 financial results on May 11, 2023.

What time is the MiNK Therapeutics conference call?

The conference call is scheduled for 8:30 a.m. ET on May 11, 2023.

How can I access the MiNK Therapeutics conference call webcast?

The webcast can be accessed from MiNK Therapeutics' Events & Presentations page.

What type of therapies does MiNK Therapeutics develop?

MiNK Therapeutics develops allogeneic, off-the-shelf iNKT cell therapies for cancer.

What are the contact emails for MiNK Therapeutics?

You can reach them at communications@minktherapeutics.com or investor@minktherapeutics.com.

Tags: INKT Viatris Investor Conferences Healthcare MiNK Therapeutics iNKT cell therapies biopharmaceuticals NASDAQ INKT financial results
Last updated: Apr 27, 2023